Drug recall · September 2, 2020
Losartan Potassium Tablets USP recall
Why: Failed Tablet/Capsule Specification; complaint of bulging tablet
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Losartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ by Hetero Labs, Limited, Mahabubragar, India
- Lots / codes
Batch # LOA19357A, exp. date 09/2021
- Quantity
- 43,512 bottles
- Company
- Hetero Labs Limited (Unit V), Badepalle, N/A
- Distribution
- Product was distributed to major wholesalers/distributors throughout the United States.
- Initiated
- August 6, 2020 · Voluntary: Firm initiated
- Classified
- August 26, 2020
- Reported
- September 2, 2020
- Ended
- January 24, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Losartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.